SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Greg22 who wrote (18666)2/11/1999 2:09:00 PM
From: John M. Gelnieau  Read Replies (1) of 23519
 
My experience has been that reverse splits are the KOD!

All VVUS needs to understand is that word of mouth will not create enough of a market. They need partner and marketing programs to position MUSE into the market. That will impact more improvement on the balance sheet and operating statements than any other strategy I know of.

This one is so simple. Made money last quarter. Have substantial incremental manufacturing capacity which means MUSE fixed cost to high. Every incremental unit lowers per unit fixed cost which increases profit. To a point we know that this increased volume can be supported with previously written off raw materials.

IMHO, VVUS needs scripts plain and simple.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext